Bethesda, Maryland-based Telcare, which offers an FDA cleared cellular-enabled glucose monitor and its cloud-based companion system, has scooped up $25.5 million in funding led by new backer Sequoia Capital with participation from its existing investor Qualcomm Life Fund. Telcare will use the funds to build out its marketing, sales, research and development. Telcare had previously raised about $4...
